Company intelligence / Profile preview

Royal Canin

Ownership: Private
Employees: ~7000
Development stage: Commercial

Overview

Royal Canin develops and markets specialized cat and dog food based on scientific research into breed-, size-, age-, and condition-specific nutritional requirements. The company has pioneered breed-specific diets and veterinary prescription diets for companion animals[2][6][7]. No clinical trial results as per pharmaceutical standards; efficacy demonstrated through market adoption and veterinary endorsement.

Industry: Food & Nutrition

Drug pipeline

5 assets

Gastrointestinal Low Fat + Hydrolyzed Protein Canine

Commercial

Indications: Gastrointestinal health, Food sensitivities in dogs

4 more assets in the full pipeline.

Request access →

Partnerships

TerraCycle recycling program partnership[3]collaborations with breeders/veterinary professionals globally.

Beyond the preview

Go deeper on Royal Canin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royal Canin.

Explore the full profile